Antifibrotic Composition with Antioxidant Stability Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional pharmaceutical formulations of 3-(4-(dihexylamino)-3-fluorophenyl)-2,6-dimethylpyrimidin-4(3H)-one (compound having formula (I)) or its pharmaceutically acceptable salts, such as hydrochloride, suffer from poor stability when combined with excipients, leading to increased impurity formation during storage.
Innovation Solution
Combining the compound with an antioxidant, particularly one that reacts with free radicals, enhances the stability of the pharmaceutical formulation by reducing impurity formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the compound is combined with conventional excipients to form pharmaceutical formulations, then the formulation can be prepared for human consumption, but the stability of the formulation becomes very poor and impurity content increases
Solution Approach 1:
The patent introduces an antioxidant as an intermediary substance that mediates between the compound and excipients. This antioxidant reacts with free radicals generated during formulation preparation and storage, preventing the compound from degrading into impurities while allowing conventional excipients to be used in the formulation.
Solution Approach 2:
The patent converts the harmful effect of free radical formation (which causes degradation) into a beneficial process by using the antioxidant to react with these free radicals. The antioxidant sacrifices itself by reacting with free radicals, thereby protecting the compound and transforming a harmful degradation pathway into a controlled, beneficial reaction that maintains formulation stability.
2Reliability
If the compound is stored long-term without antioxidant protection, then no impurities are produced initially, but impurity content increases over time due to oxidation
Solution Approach 1:
The patent applies preliminary action by incorporating the antioxidant into the formulation before storage begins. The antioxidant is pre-positioned in the formulation to immediately react with and neutralize free radicals as they form during storage, preventing oxidation-induced degradation from occurring in the first place rather than addressing it after it begins.
Solution Approach 2:
The patent ensures continuity of useful action by using the antioxidant to continuously neutralize free radicals throughout the entire storage period. This continuous protection prevents the gradual accumulation of impurities over time, maintaining the compound's stability and quality from initial storage through long-term storage conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition maintains stability, ensuring easy storage, controlled quality, high bioavailability, and high safety, with improved patient compliance.
Implementation Method 1
when the compound or its pharmaceutically acceptable salt such as hydrochloride is combined with an antioxidant that reacts with free radicals, the stability of the pharmaceutical formulation is better
Data Source
AI summary
An antifibrotic composition includes 3-(4-(dihexylamino)-3-fluorophenyl)-2,6-dimethylpyrimidin-4(3H)-one or a pharmaceutically acceptable salt thereof and an antioxidant. The composition has the advantages of easy storage, stable and controllable quality, high bioavailability, etc. Moreover, the composition has a high efficacy and a high safety, and the compliance of a patient taking the composition is good.